Augmedix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Augmedix generated cash of -$15,441,000, which is more than the previous year. Cash used in financing activities reached the amount of $43,370,000 last year. Net change in cash is therefore $24,966,000.
Cash Flow
| 2019 | -14.64M | -823.01K | 17.16M |
|---|---|---|---|
| 2020 | -14.39M | -647.01K | 26.41M |
| 2021 | -18.59M | -611K | 37.82M |
| 2022 | -16.77M | -1.40M | -1.23M |
| 2023 | -15.44M | -3.10M | 43.37M |
AUGX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 21.37M | 41.58M | 22.97M | 11.60M | 9.91M |
Operating activities | |||||
Net income | -19.17M | -24.44M | -17.85M | -15.60M | -18.49M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.09M | 856K | 691K | 867K | 949.00K |
Stock-based compensation expense | 2.47M | 2.11M | 1.38M | 668K | 397.09K |
| Deferred income tax benefit | 2.47M | 2.11M | 1.38M | 668K | 397.09K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -2.39M | 786K | -4.43M | -401.73K | -126.2K |
Inventories | 0 | 0 | 1.04M | -149.26K | 450.44K |
Accounts payable | -947K | 88K | 1.01M | -396.86K | 373.74K |
Cash generated by operating activities | -15.44M | -16.77M | -18.59M | -14.39M | -14.64M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.10M | -1.40M | -611K | -647.01K | -823.01K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -3.10M | -1.40M | -611K | -647.01K | -823.01K |
Financing activities | |||||
Common Stock Issued | 38.73M | 30K | 40M | 27.41M | 15.27M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 5M | -1.12M | -12.96M | -2.18M | 1.94M |
Cash used in financing activities | 43.37M | -1.23M | 37.82M | 26.41M | 17.16M |
Net Change In Cash | 24.96M | -19.59M | 18.61M | 11.36M | 1.68M |
Cash at end of period | 46.34M | 21.98M | 41.58M | 22.97M | 11.60M |
| Data source | Data source | Data source | Data source | Data source |